CLINICAL & TRANSLATIONAL IMMUNOLOGY

 

Clinical & Translational Immunology

The Official Open Access Journal of the ASI

2022 Impact Factor: 5.8
2022 Scopus CiteScore: 9.6

Clinical & Translational Immunology cover image


CLINICAL & TRANSLATIONAL IMMUNOLOGY COVERS:

  • Cancer biology
  • Cardiovascular research
  • Gene therapy
  • Immunology
  • Vaccine development
  • Disease pathogenesis and therapy at the earliest phases of investigation

FEATURES OF CLINICAL & TRANSLATIONAL IMMUNOLOGY INCLUDE:

  • Rapid Review Process
  • Average Time to First Decision of 13 days (2022 manuscripts)
  • Open Access – anyone can download and read your paper 
  • 2022 Impact Factor 5.8
  • 2022 Scopus CiteScore 9.6
  • Now listed on PubMed Central
  • Full peer review 
  • Original Articles, Reviews, Case Reports, Letters to Editors, Theoretical Articles, Short Communications
  • Special Features 
  • Supported by a distinguished and international Editorial Board
  • Member of COPE for responsible publication ethics  
  • Publishes only the most important advances in biomedical research
  • Eligibility for the CTI Social Impact Award

ADDITIONAL BENEFITS FOR ASI MEMBERS

  • Receive a 20% discount off the cost of publishing in CTI*
  • Be in the running for the award of ‘CTI Publication of the Year’, which also includes a speakers slot at the ASI annual meeting*** 

*Eligible only to current financial ASI members. To receive the member-only code, please contact us. For further information about the Wiley-CAUL agreement, which covers the APC (Article Processing Charge) for authors, see https://authorservices.wiley.com/author-resources/Journal-Authors/open-access/affiliation-policies-payments/institutional-funder-payments.html
***Awarded to the best publication from a current financial ASI member who is first author.

CTI website Submit a manuscript Download the CTI flyer

Follow us on Twitter @ClinTransImmuno 

© ASI 2021

ABN 76 330 189 856 | ARBN 084 971 559 | CAV A0016266B